← back to search

Yuntao Li

Universidad del Noreste · ES
Area of research
Artificial Intelligence · Aerospace Engineering
Research interest
Research interests include Topic Modeling, Combustion and Detonation Processes, Fire dynamics and safety research, and Glioma Diagnosis and Treatment.
h-index
34
citations
4,609
works
305
NIH funding
primary concept
email

Recent publications

Macrophage migration inhibitory factor mediates joint capsule fibrosis via facilitating phospholipid metabolite PGE2 production in fibroblasts
Cellular and Molecular Life Sciences 2025cited by 10position: middledoi
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study
Breast Cancer Research 2025cited by 3position: middledoi
Burden of subarachnoid hemorrhage in Asia and ARIMA model prediction trends from 1990 to 2021
Scientific Reports 2025cited by 3position: firstdoi
Neoadjuvant chemotherapy is not necessarily applicable to patients with LN1-3 positive Luminal-B type operable breast cancer
Scientific Reports 2025cited by 0position: lastdoi
Functional mechanism and clinical implications of LINC00339 in delayed fracture healing
Journal of Orthopaedic Surgery and Research 2024cited by 23position: firstdoi
Enriched environment enhances angiogenesis in ischemic stroke through SDF-1/CXCR4/AKT/mTOR pathway
Cellular Signalling 2024cited by 3position: lastdoi
miR-30d-5p inhibits proliferation, invasion and migration of breast cancer cells by targeting SERPINE1 and promoting fatty acid β-oxidation
Aging 2024cited by 1position: lastdoi
Abstract PO2-02-05: CDK4/6 inhibitor dalpiciclib combined with letrozole as neoadjuvant therapy in postmenopausal patients with hormone receptor-positive, HER2-negative stage II-III breast cancer: a single-arm exploratory trial
Cancer Research 2024cited by 1position: middledoi
A phase II trial comparing dalpiciclib in combination with letrozole versus standard chemotherapy as neoadjuvant therapy in patients with high-risk HR- positive HER-2 negative breast cancer: DARLING-02.
Journal of Clinical Oncology 2024cited by 1position: middledoi
Recent advances in combatting bacterial infections <i>via</i> well-designed metallacycles/metallacages
Dalton Transactions 2023cited by 9position: middledoi
Effect of Surgical Clipping versus Endovascular Coiling on the Incidence of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Multicenter Observational Cohort Study with Propensity Score Matching
World Neurosurgery 2023cited by 8position: middledoi
Correlation between the rate of morphological changes and rupture of intracranial aneurysms during one cardiac cycle analyzed by 4D-CTA
Frontiers in Neurology 2023cited by 3position: lastdoi
Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer
Frontiers in Oncology 2023cited by 1position: middledoi
Identification of autophagy related genes predicting response of trastuzumab resistance in breast cancer patients
Research Square 2023cited by 0position: middledoi
Comparison of Conventional Logistic Regression and Machine Learning Methods for Predicting Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Multicentric Observational Cohort Study
Frontiers in Aging Neuroscience 2022cited by 44position: middledoi
Variations of Bacterial and Diazotrophic Community Assemblies throughout the Soil Profile in Distinct Paddy Soil Types and Their Contributions to Soil Functionality
mSystems 2022cited by 20position: middledoi
A Comparison of LASSO Regression and Tree-Based Models for Delayed Cerebral Ischemia in Elderly Patients With Subarachnoid Hemorrhage
Frontiers in Neurology 2022cited by 17position: middledoi
Improving Semantic Matching through Dependency-Enhanced Pre-trained Model with Adaptive Fusion
2022cited by 14position: middledoi
Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study
Frontiers in Oncology 2022cited by 13position: middledoi
Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model
Scientific Reports 2022cited by 2position: middledoi
A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy.
Journal of Clinical Oncology 2022cited by 1position: middledoi
Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
Cell Death and Disease 2021cited by 41position: middledoi
Systemic thrombolysis and anticoagulation therapy for catheter-related right atrial thrombosis caused by TIVAP: A case report and review of the literature
The Journal of Vascular Access 2021cited by 7position: lastdoi
Development and external validation of a dynamic nomogram for delayed cerebral ischaemia after aneurysmal subarachnoid hemorrhage: a study protocol for a multicentre retrospective cohort study
BMJ Open 2021cited by 2position: middledoi
Long non-coding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple negative breast cancer
Research Square (Research Square) 2020cited by 3position: middledoi
The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis
Annals of Intensive Care 2019cited by 101position: middledoi
Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)
Scientific Reports 2019cited by 20position: middledoi
Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?
World Journal of Surgery 2019cited by 20position: middledoi
Breast Cancer and Lipid Metabolism
Translational bioinformatics 2018cited by 5position: middledoi
Fast and sensitive detection of foodborne pathogen using electrochemical impedance analysis, urease catalysis and microfluidics
Biosensors and Bioelectronics 2016cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lina Zhang · Hebei Medical University6 papers (2019–2025)Zhongzhou Su · Zhejiang University5 papers (2021–2023)Cuizhi Geng · Hebei Medical University5 papers (2022–2025)Qianxue Chen · Huzhou University4 papers (2021–2023)Xu Gao · Harbin University of Science and Technology4 papers (2021–2023)Yanshou Zhang · Hebei Medical University4 papers (2021–2025)Ping Hu · Shanghai University of Traditional Chinese Medicine4 papers (2021–2023)Xiangshun Kong · Hebei Medical University4 papers (2022–2025)Meiqi Wang · Hebei Medical University3 papers (2022–2025)Gang Deng · Huazhong University of Science and Technology3 papers (2021–2022)Tiantian Tang · Hebei Medical University3 papers (2019–2025) · 3 papers (2024–2025) · 3 papers (2024–2025)Jianhan Lin · Ministry of Education of the People's Republic of China3 papers (2014–2016) · 3 papers (2021–2022) · 3 papers (2024–2025)Xiaochun Wang · Shanxi Medical University3 papers (2024–2025)Yang Xu · University of Iowa3 papers (2021–2022)Yueping Liu · Hebei Medical University3 papers (2022–2025)Zhisheng Zhang · Shanghai Medical College of Fudan University2 papers (2024–2025)